Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Clinical adverse events in prehospital patients with ST-elevation myocardial infarction transported to a percutaneous coronary intervention centre by basic life support paramedics in a rural region.

Bussières S, Bégin F, Leblanc PA, Tanguay A, Paradis JM, Hébert D, Fleet R.

CJEM. 2018 Nov;20(6):857-864. doi: 10.1017/cem.2018.383. Epub 2018 Jun 5.

PMID:
29866213
2.

BET 1: Continuous flow insufflation of oxygen in out-of-hospital cardiac arrest.

LeBlanc PA, Nadeau A.

Emerg Med J. 2018 Jan;35(1):65-66. doi: 10.1136/emermed-2017-207366.1. Review.

PMID:
29247136
3.

Traumatic Rupture of an Intermediate Tendon in a Patient with Patellar Duplication.

Pelet S, Hébert M, Balatri A, LeBlanc PA.

Case Rep Orthop. 2017;2017:9475148. doi: 10.1155/2017/9475148. Epub 2017 Jan 31.

4.

Traffic in the operating room during joint replacement is a multidisciplinary problem.

Bédard M, Pelletier-Roy R, Angers-Goulet M, Leblanc PA, Pelet S.

Can J Surg. 2015 Aug;58(4):232-6.

5.

Complete nucleotide sequences of plasmids pACK2 and pACK5 from Staphylococcus simulans biovar staphylolyticus.

Gargis AS, Heath LS, Heath HE, Leblanc PA, Gargis SR, Harris TH, Sloan GL.

Plasmid. 2013 May;69(3):257-62. doi: 10.1016/j.plasmid.2013.01.008. Epub 2013 Feb 6.

PMID:
23396145
6.

Monocarboxylate transporters are not responsible for Cr(3+) transport from endosomes.

Rhodes NR, LeBlanc PA, Rasco JF, Vincent JB.

Biol Trace Elem Res. 2012 Sep;148(3):409-14. doi: 10.1007/s12011-012-9381-1. Epub 2012 Mar 6.

PMID:
22391796
7.

Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.

Gargis SR, Heath HE, LeBlanc PA, Dekker L, Simmonds RS, Sloan GL.

Appl Environ Microbiol. 2010 Oct;76(20):6944-6. doi: 10.1128/AEM.01066-10. Epub 2010 Aug 20.

8.

Complete nucleotide sequences of plasmids pACK1 and pACK3 from Staphylococcus simulans biovar staphylolyticus.

Gargis AS, Tate AH, Heath LS, Heath HE, Leblanc PA, Sloan GL.

Plasmid. 2010 Sep;64(2):104-9. doi: 10.1016/j.plasmid.2010.05.002. Epub 2010 May 21.

PMID:
20493903
9.

Characterization of pACK4, a mobilizable plasmid from Staphylococcus simulans biovar staphylolyticus.

Gargis AS, Heath LS, Heath HE, LeBlanc PA, Sloan GL.

Plasmid. 2009 Nov;62(3):201-5. doi: 10.1016/j.plasmid.2009.08.003. Epub 2009 Aug 26.

PMID:
19715721
10.

Zif, the zoocin A immunity factor, is a FemABX-like immunity protein with a novel mode of action.

Gargis SR, Gargis AS, Heath HE, Heath LS, LeBlanc PA, Senn MM, Berger-Bächi B, Simmonds RS, Sloan GL.

Appl Environ Microbiol. 2009 Oct;75(19):6205-10. doi: 10.1128/AEM.01011-09. Epub 2009 Aug 14.

11.

Use of 4-sulfophenyl isothiocyanate labeling and mass spectrometry to determine the site of action of the streptococcolytic peptidoglycan hydrolase zoocin A.

Gargis SR, Heath HE, Heath LS, Leblanc PA, Simmonds RS, Abbott BD, Timkovich R, Sloan GL.

Appl Environ Microbiol. 2009 Jan;75(1):72-7. doi: 10.1128/AEM.01647-08. Epub 2008 Oct 31.

12.

Plasmid-specified FemABX-like immunity factor in Staphylococcus sciuri DD 4747.

Heath LS, Gargis SR, Smithberg SR, Johnson HP, Heath HE, Leblanc PA, Sloan GL.

FEMS Microbiol Lett. 2005 Aug 15;249(2):227-31.

13.

The streptococcolytic enzyme zoocin A is a penicillin-binding protein.

Heath LS, Heath HE, LeBlanc PA, Smithberg SR, Dufour M, Simmonds RS, Sloan GL.

FEMS Microbiol Lett. 2004 Jul 15;236(2):205-11.

14.
15.

Expression of the genes for lysostaphin and lysostaphin resistance in streptococci.

Heath Farris M, Heath LS, Heath HE, LeBlanc PA, Simmonds RS, Sloan GL.

FEMS Microbiol Lett. 2003 Nov 7;228(1):115-9.

16.

The effect of physical activity and fitness on specific antibody production in college students.

Schuler PB, Lloyd LK, Leblanc PA, Clapp TA, Abadie BR, Collins RK.

J Sports Med Phys Fitness. 1999 Sep;39(3):233-9.

PMID:
10573666
17.

Moveable intraoperative magnetic resonance imaging systems in the OR.

Leblanc PA, Aubry B, Gervin M.

AORN J. 1999 Aug;70(2):254-5, 258-60, 263 passim.

PMID:
10472386
19.

Wall-associated processing of extracellular enzymes of Staphylococcus simulans biovar staphylolyticus.

Bunn WJ, Heath HE, LeBlanc PA, Sloan GL.

FEMS Microbiol Lett. 1998 Aug 1;165(1):123-7.

20.

Ribotype delineation and description of Staphylococcus sciuri subspecies and their potential as reservoirs of methicillin resistance and staphylolytic enzyme genes.

Kloos WE, Ballard DN, Webster JA, Hubner RJ, Tomasz A, Couto I, Sloan GL, Dehart HP, Fiedler F, Schubert K, de Lencastre H, Sanches IS, Heath HE, Leblanc PA, Ljungh A.

Int J Syst Bacteriol. 1997 Apr;47(2):313-23. Erratum in: Int J Syst Bacteriol 1997 Oct;47(4):1279.

PMID:
9103615
21.

Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors.

Wang LL, Mehta IK, LeBlanc PA, Yokoyama WM.

J Immunol. 1997 Jan 1;158(1):13-7.

PMID:
8977170
22.
23.

The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.

DeHart HP, Heath HE, Heath LS, LeBlanc PA, Sloan GL.

Appl Environ Microbiol. 1995 Apr;61(4):1475-9. Erratum in: Appl Environ Microbiol 1995 Jul;61(7):2811.

24.

Induction of macrophage binding to virally infected cells by low levels of lipopolysaccharide.

Derrick SC, LeBlanc PA.

J Leukoc Biol. 1995 Apr;57(4):569-73.

PMID:
7722416
25.

Plasmid-encoded catalase of Staphylococcus simulans biovar staphylolyticus.

Fondren LM, Sloan GL, LeBlanc PA, Heath HE.

FEMS Microbiol Lett. 1994 Apr 1;117(2):231-5.

PMID:
8181729
27.

Extracellular proteolytic activation of bacteriolytic peptidoglycan hydrolases of Staphylococcus simulans biovar staphylolyticus.

Neumann VC, Heath HE, LeBlanc PA, Sloan GL.

FEMS Microbiol Lett. 1993 Jun 15;110(2):205-11.

PMID:
8102340
28.

EGTA inhibition of DNase activity in commercial lysostaphin preparations.

Malatesta ML, Heath HE, LeBlanc PA, Sloan GL.

Biotechniques. 1992 Jan;12(1):70, 72. No abstract available.

PMID:
1734926
29.

Characteristics of extracellular protein production by a plasmidless derivative of Staphylococcus simulans biovar staphylolyticus.

Nitterauer JD, Heath HE, Heath LS, LeBlanc PA, Sloan GL.

FEMS Microbiol Lett. 1991 Nov 1;68(1):23-6.

PMID:
1769550
30.
31.

Macrophage activation for cytolysis of virally infected target cells.

LeBlanc PA.

J Leukoc Biol. 1989 Apr;45(4):345-52.

PMID:
2467959
32.
33.

Lymphocyte hybridomas: 1986.

LeBlanc PA.

Year Immunol. 1988;3:247-59. Review. No abstract available.

PMID:
3327313
34.

Lymphocyte hybridomas: monoclonal antibodies and more.

LeBlanc PA.

Year Immunol. 1986;2:187-94. Review. No abstract available.

PMID:
3033944
35.

Antiviral activity of Bordetella pertussis vaccine-elicited peritoneal exudate cells.

Baggett DW, LeBlanc PA, Allison FS, Thomley MJ, Winters AL.

J Immunopharmacol. 1986;8(4):589-609.

PMID:
3027186
36.

Modification of Epstein-Barr virus replication by tunicamycin.

Hutt-Fletcher LM, Balachandran N, LeBlanc PA.

J Virol. 1986 Jan;57(1):117-23.

37.
38.

Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.

Pace JL, Russell SW, LeBlanc PA, Murasko DM.

J Immunol. 1985 Feb;134(2):977-81.

PMID:
2578167
39.

Heterogeneity among macrophages cultured from mouse bone marrow. Morphologic, cytochemical and flow cytometric analyses.

Leung KP, Russell SW, LeBlanc PA, Caballero S.

Cell Tissue Res. 1985;239(3):693-701.

PMID:
3986887
40.

Monoclonal antibodies: novel to Nobel.

LeBlanc PA.

Year Immunol. 1985:136-42. No abstract available.

PMID:
3843292
41.

Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, LeBlanc PA, Hein A, Caulfield JP, Austen KF, Stevens RL.

J Immunol. 1984 Mar;132(3):1479-86.

PMID:
6198393
42.
43.

Uses of monoclonal antibodies: 1983.

LeBlanc PA.

Surv Immunol Res. 1984;3(2-3):135-7. No abstract available.

PMID:
6201985
44.

Two classes of mouse mast cells delineated by monoclonal antibodies.

Katz HR, LeBlanc PA, Russell SW.

Proc Natl Acad Sci U S A. 1983 Oct;80(19):5916-8.

45.

Monoclonal antibodies and mononuclear phagocytes. An update.

LeBlanc PA.

Surv Immunol Res. 1983;2(3):252-4. No abstract available.

PMID:
6201982
46.

Mouse mononuclear phagocyte antigenic heterogeneity detected by monoclonal antibodies.

LeBlanc PA, Russell SW, Chang SM.

J Reticuloendothel Soc. 1982 Sep;32(3):219-31.

PMID:
6185677
47.

An antigenic determinant shared by mononuclear phagocytes and mast cells, as defined by monoclonal antibody.

Katz HR, LeBlanc PA, Russell SW.

J Reticuloendothel Soc. 1981 Nov;30(5):439-43. No abstract available.

PMID:
6172586
48.

A discrete population of mononuclear phagocytes detected by monoclonal antibody.

LeBlanc PA, Katz HR, Russell SW.

Infect Immun. 1980 Aug;29(2):520-5.

49.

Staphylococcal protein A assay for detection of antibody directed at renal cancer cells.

Leblanc PA, Taffet SM, Fried FA, Avis FP.

J Urol. 1979 Jun;121(6):724-7.

PMID:
458941
50.

Supplemental Content

Loading ...
Support Center